History

2014:

DPE (Deutsche Private Equity) acquires PharmaZell.

2013:

PharmaZell takes over the former Abbott facility in Liestal/Switzerland.

2011:

Ergon Capital Partners (Belgium) acquires Pharmazell and integrates them together with Farmabios (Italy) to Zellbios S.A.

2010:

Pharmazell launches its formulation R&D unit in Vizag, India with lab and pilot scale formulation development.

2009:

PharmaZell starts a new small scale production unit in Vizag.

2008:

PharmaZell builds a new production plant in Vizag (India) and the production of Mesalamine starts. PharmaZell opens a new R&D center in Vizag as well.

2006:

Today‘s PharmaZell is created through a management buyout of the Noveon pharmaceutical business with the help of private equity investor Auctus. The Raubling headquarters near Munich become the Company‘s registered office.

2001:

The performance material segment is spun off from BF Goodrich under the name of Noveon, with the active pharmaceutical ingredients business now being managed as Noveon GmbH & Co. KG.

1998:

BF Goodrich acquires the Freedom Chemical Company.

1995:

Diamalt builds its first production site in Chennai (the former Madras) in India to produce Cysteine products.

1994:

Diamalt is acquired by Freedom Chemical Company and continues to be run under its old name of Diamalt GmbH.

1979:

Schering AG, a pharmaceutical company, acquires a majority of Diamalt shares and begins actively investing into Raubling. The company is steadily growing.

1969:

More or less 20 years after the company‘s foundation, PharmaZell gets acquired – the first of several acquisitions
to follow. Diamalt AG buys PharmaZell and expands the site‘s chemical operations.

1947:

The name PharmaZell appears: PharmaZell is newly established in Raubling as a subsidiary of Aschaffenburger
Zellstoffwerke AG paper mill near Munich and begins producing active pharmaceutical ingredients.